SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-025048
Filing Date
2023-02-24
Accepted
2023-02-24 08:39:59
Documents
18
Period of Report
2023-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237769d1_8k.htm   iXBRL 8-K 38147
2 EXHIBIT 1,1 tm237769d1_ex1-1.htm EX-1.1 303552
3 EXHIBIT 4.1 tm237769d1_ex4-1.htm EX-4.1 98434
4 EXHIBIT 5.1 tm237769d1_ex5-1.htm EX-5.1 13232
5 EXHIBIT 99.1 tm237769d1_ex99-1.htm EX-99.1 5908
6 EXHIBIT 99.2 tm237769d1_ex99-2.htm EX-99.2 9024
10 GRAPHIC tm237769d1_ex5-1img001.jpg GRAPHIC 9198
  Complete submission text file 0001104659-23-025048.txt   766809

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sls-20230223.xsd EX-101.SCH 3254
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20230223_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20230223_pre.xml EX-101.PRE 22378
12 EXTRACTED XBRL INSTANCE DOCUMENT tm237769d1_8k_htm.xml XML 3608
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 23662595
SIC: 2834 Pharmaceutical Preparations